logo
Researchers urge caution when using ChatGPT to self-diagnose illnesses

Researchers urge caution when using ChatGPT to self-diagnose illnesses

CTV News2 days ago

Researchers examined the use of ChatGPT-4 to self-diagnose health problems.
As Canadians increasingly turn to artificial intelligence for quick answers about health problems, a new study warns relying on tools like ChatGPT for self-diagnosis could be risky.
A team, led by researchers at the University of Waterloo, evaluated the performance of ChatGPT-4, a large language model (LLM) released by OpenAI.
The chatbot was asked a series of open-ended medical questions based on scenarios modified from a medical licensing exam.
The findings were striking. Only 31 per cent of ChatGPT's responses were deemed entirely correct, and just 34 per cent were considered clear.
Troy Zada Sirisha Rambhatla
PhD student Troy Zada and Dr. Sirisha Rambhatla at the University of Waterloo are part of the research team.
'So, not that high,' said Troy Zada, a PhD student at the University of Waterloo who led the research team. 'If it is telling you that this is the right answer, even though it's wrong, that's a big problem, right?''
The researchers compared ChatGPT-4 with its earlier 3.5 version and found significant improvements, but not enough.
In one example, the chatbot confidently diagnosed a patient's rash as a reaction to laundry detergent. In reality, it was caused by latex gloves — a key detail missed by the AI, which had been told the patient studied mortuary science and used gloves.
The researchers concluded that LLMs are not yet reliable enough to replace medical professionals and should be used with caution when it comes to health matters. This is despite studies that have found AI chatbots can best human doctors in certain situations and pass medical exams involving multiple choice questions.
Zada said he's not suggesting people stop using ChatGPT for medical information, but they must be aware of its limitations and potential for misinformation.
'It could tell you everything is fine when there's actually a serious underlying issue,' said Zada.
He says it could also offer up information that would make someone needlessly worry.
Millions of Canadians currently do not have a family doctor and there are concerns some may be relying on artificial intelligence to diagnose health problems, even though AI chatbots often advise users to consult an actual doctor.
The researchers also noted the chatbots lack accountability, whereas a human doctor can face severe consequences for errors, such as having their licence revoked or being charged with medical malpractice.
While the researchers note ChatGPT did not get any of the answers spectacularly wrong, they have some simple advice.
'When you do get a response be sure to validate that response,' said Zada.
Dr. Amrit Kirpalani agrees. He's a pediatric nephrologist and assistant professor at Western University who has studied AI in medicine and has noticed more patients and their family members bringing up AI platforms such as ChatGPT.
He believes doctors should initiate conversations about its use with patients because some may be hesitant to talk about it.
'Nobody wants to tell their doctor that they went on ChatGPT and it told them something different,' says Kirpalani.
He'd prefer patients discuss a chatbot's response with a physician, especially since an AI can sometimes be even more persuasive than a human.
'I'm not sure I could be as convincing as an AI tool. They can explain some things in a much more simple and understandable way,' says Kirpalani. 'But the accuracy isn't always there. So it could be so convincing even when it's wrong.'
He likens AI to another familiar online tool.
'I kind of use the Wikipedia analogy of, it can be a great source of information, but it shouldn't be your primary source. It can be a jumping-off point.'
The researchers also acknowledge as LLMs continue to improve, they could eventually be reliably used in a medical setting. But for now, Zada has this to say: 'Don't blindly accept the results.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dear Broadcom Stock Fans, Mark Your Calendars for June 5
Dear Broadcom Stock Fans, Mark Your Calendars for June 5

Globe and Mail

time23 minutes ago

  • Globe and Mail

Dear Broadcom Stock Fans, Mark Your Calendars for June 5

Broadcom (AVGO) has weathered its share of turbulence this year, first from the emergence of Chinese startup DeepSeek's competing artificial intelligence (AI) model, then from market jitters tied to tariff threats under President Donald Trump that shook the broader chip sector. Yet, the stock has managed to hold firm. The company's deep entrenchment in AI data center infrastructure, with heavyweight clients such as Alphabet (GOOGL), Meta (META), and TikTok's parent company, ByteDance, continues to anchor its relevance. It's also developing AI inference chips for the likes of ChatGPT maker OpenAI and Apple (AAPL), adding further weight to its positioning. In fact, its most recent earnings reported in March not only topped Wall Street expectations, but also showcased growing momentum in its AI business, a development that certainly caught investors' attention. So, with Broadcom now gearing up to report its fiscal second-quarter results on June 5, the spotlight is back on the stock for a closer evaluation. About Broadcom Stock Broadcom's (AVGO) roots stretch back to 1961, but the company as we know it today took shape in 2016 with the merger of Avago Technologies and Broadcom Corporation. The California-based company has grown into a major force in the tech world, designing and delivering a wide array of semiconductor and infrastructure software solutions. Its technology powers everything from data centers and broadband networks to wireless systems, storage platforms, and industrial applications, making it a key player across multiple high-impact markets. With a commanding market cap nearing $1.2 trillion, Broadcom has stayed resilient in 2025, brushing off broader market turbulence. Year to date, the stock is up about 10%, edging past the marginal gains of the S&P 500 Index ($SPX). However, the real spark has emerged lately, with shares having rocketed 25% in just the last month. Zoom out to a full year, and Broadcom's performance looks even more impressive, boasting a 92.8% return that leaves the SPX in the dust. Broadcom Shares Soar After Q1 Earnings In its fiscal 2025 first-quarter earnings report released on March 6, Broadcom delivered a standout performance, posting revenue of $14.9 billion, beating estimates of $14.6 billion and marking a strong 25% year-over-year increase. Even more impressive was its adjusted earnings per share, which shot up 45.5% annually to $1.60, well above Wall Street's forecast of $1.51. Adjusted EBITDA also surged 41% year over year, reaching $10.1 billion. Breaking down the results, the infrastructure software segment saw revenue climb more than 47% to $6.7 billion. But the real growth engine was Broadcom's booming AI business, which has become central to its performance. As a key supplier of AI data center infrastructure, Broadcom not only builds custom AI chips in partnership with Google but also provides the vital networking components that connect thousands of chips to power cutting-edge AI systems. AI-related revenue alone reached $4.1 billion in the quarter, a jaw-dropping 77% year-over-year increase, helping propel its semiconductor solutions segment to $8.2 billion, up 11% from the previous year. This wave of strong results sent Broadcom's stock soaring almost 8.6% on March 7. Dear Broadcom Stock Fans, Mark Your Calendars for June 5 As Broadcom gets set to release its second-quarter earnings after the bell on June 5, management is striking an upbeat note. CEO Hock Tan signaled strong momentum ahead, stating, 'We expect continued strength in AI semiconductor revenue of $4.4 billion in Q2, as hyperscale partners continue to invest in AI XPUs and connectivity solutions for AI data centers.' The company is also projecting total revenue of approximately $14.9 billion for the quarter, with adjusted EBITDA expected to account for 66% of that figure, reflecting Broadcom's robust operating model and the enduring strength of its AI-driven growth. Analysts tracking the company are eyeing a sharp 55.2% jump in Broadcom's quarterly earnings compared to last year. What Do Analysts Expect for Broadcom Stock? Broadcom recently scored a fresh vote of confidence from Redburn Atlantic, which initiated coverage with a 'Buy' rating, citing the company's dominant position in application-specific integrated circuits (ASICs) as a key growth catalyst. Analyst Mike Harrison set an ambitious price target of $301, the highest on Wall Street for now. And Redburn isn't alone. With the company's earnings on the horizon, AVGO is drawing broad support across Wall Street. Analysts continue to rally behind the stock, with the consensus firmly planted in 'Strong Buy' territory, fueled by confidence in the company's AI strength and robust fundamentals. Of the 34 analysts offering recommendations, 30 give it a solid 'Strong Buy,' one suggests a 'Moderate Buy,' and the remaining three give a 'Hold.' While the average analyst price target of $249.37 is below its current trading price, Redburn Atlantic's Street-high target of $301 indicates that the stock can rally as much as 18% from here.

Constellation Energy Just Landed a Major Meta Platforms Deal. How Should You Play the Nuclear Energy Stock Here?
Constellation Energy Just Landed a Major Meta Platforms Deal. How Should You Play the Nuclear Energy Stock Here?

Globe and Mail

time23 minutes ago

  • Globe and Mail

Constellation Energy Just Landed a Major Meta Platforms Deal. How Should You Play the Nuclear Energy Stock Here?

Constellation Energy (CEG) shares are inching up on Tuesday, June 3 after Meta Platforms (META) announced a 20-year nuclear power agreement with the largest U.S. producer of carbon-free energy. Meta has agreed to buy more than 1 gigawatt of energy, or the entire output from CEG's nuclear facility in Illinois, to meet the ever-increasing power demand of its AI data centers. The agreement will commence in June 2027. Including today's gains, Constellation Energy stock is up nearly 100% versus its year-to-date low in early April. What Meta's Deal Means for Constellation Energy Stock Meta's long-term power purchase agreement (PPA) is a meaningful positive for CEG investors since it ensures a stable revenue stream for the nuclear energy company. Additionally, this deal secures the future of the company's Clinton facility, which faced potential closure after its zero-emission credits expire in 2027. Onboarding a tech titan reinforces Constellation Energy's position in the global market for carbon-free energy, which could drive other artificial intelligence companies to its nuclear facilities as well. All in all, Meta's announcement not only improves visibility into CEG's future earnings and its overall growth prospects – it actually strengthens the case for nuclear power as a reliable source for AI data centers as well. Note that Constellation Energy stock also currently pays a dividend that yields 0.5%. UBS Sees Significant Further Upside in CEG Shares UBS analysts raised their price target on Constellation Energy shares in the wake of Meta's 20-year power purchase agreement on Tuesday. They expect CEG to win more PPA deals in the back half of this year, which, they believe, could drive the company's share price further up to $360, indicating potential upside of another 12% from here. Plus, Constellation's $16 billion acquisition of Calpine Corporation that's expected to close by the end of 2025 may also serve as tailwind for the nuclear energy stock, the investment firm told clients in a research note today. Other Wall Street Firms Recommend Caution on Constellation Energy Investors are still recommended caution in buying Constellation Energy stock at current levels as other Wall Street analysts are not as bullish on the Nasdaq-listed firm. While the consensus rating on CEG shares currently sits at 'Strong Buy,' the mean target of about $303 indicates potential downside of some 3% from current levels.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store